Amy Belt Raimundo
Managing Director @ Kaiser Permanente Ventures
San Francisco, United States
Amy Belt Raimundo is a Series A investor at Kaiser Permanente Ventures in San Francisco focused on Medical and Genetics. Amy Belt Raimundo joined Kaiser Permanente Ventures as managing director. Amy brings over 20 years of experience in healthcare investing, start-up and corporate operations and hospital system consulting. Immediately prior to joining Kaiser, Amy was the Chief Business Officer of digital health start-up Evidation Health founded by GE Ventures andStanford Healthcare where she led all commercial and business development activities.Previously, Amy spent close to a decade in venture capital focused on healthcare technology as a Vice President at Covidien Ventures and Advanced Technology Ventures (ATV). She led investments in Medina Medial (acquired by Medtronic) and Nevro Corporation (NYSE: NVRO) among others. Earlier in her career, Amy held operating roles at Guidant Corporation (acquired by Abbott Vascular) including leading the international launch of the Xience drug eluting stent and managing product lines across the US, Europe and Asia. She began her career as a management consultant for APM/CSC Healthcare, optimizing operations and clinical guidelines for major hospital systems. Amy is a Kauffman Venture Fellow as well as founder and president of MedtechWomen. She holds a BA in Economics from Yale University and an MBA from the University of California at Berkeley.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Amy Belt Raimundo invests in
Stages Amy Belt Raimundo invests in
Countries Amy Belt Raimundo invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 2 (33%)
- Genetics 1 (17%)
- Training 1 (17%)
- Health Care 1 (17%)
- Life Science 1 (17%)
Stage
- Series A 2 (33%)
- Series B 2 (33%)
- Series C 2 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Osso VR
|
Osso VR is a surgical training and assessment platform that uses advanced virtual reality to train and assess medical personnel. Their product offers realistic hand-based interactions in an immersive training environment containing cutting-edge procedures and devices. | $66M / Series C / Mar 24, 2022 | |
Genome Medical
|
Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health andwell-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care.The company was founded in 2016 and is based in South San Francisco, California, United States. | $60M / Series C / Aug 30, 2021 | |
|
Osso VR
|
Osso VR is a surgical training and assessment platform that uses advanced virtual reality to train and assess medical personnel. Their product offers realistic hand-based interactions in an immersive training environment containing cutting-edge procedures and devices. | $27M / Series B / Jul 07, 2021 | |
|
Osso VR
|
Osso VR is a surgical training and assessment platform that uses advanced virtual reality to train and assess medical personnel. Their product offers realistic hand-based interactions in an immersive training environment containing cutting-edge procedures and devices. | $14M / Series A / Sep 21, 2020 | |
|
Genome Medical
|
Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health andwell-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care.The company was founded in 2016 and is based in South San Francisco, California, United States. | $14M / Series B / Jul 01, 2020 | |
|
Genome Medical
|
Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health andwell-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care.The company was founded in 2016 and is based in South San Francisco, California, United States. | $11M / Series A / Jan 05, 2018 |
Co-Investors
Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente, is dedicated to forming effective partnerships with innovative companies. Kaiser Permanente Ventures invests predominantly in HCIT and services, as well as diagnostics, drug delivery and therapeutic medical devices.
Kaiser Permanente Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Amy Belt Raimundo
Managing Director
|
|||
Bryan Sivak
Managing Director
|
|||
Chris Grant
Chief Operating Officer and Executive Vice President
|
|||
Jodie Ha
Associate
|
|||
Liz Rockett
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Amy Belt Raimundo invest in?
Amy Belt Raimundo invests primarily in Medical, Genetics and Training startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Amy Belt Raimundo?
Public channels for Amy Belt Raimundo include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Amy Belt Raimundo last invest?
The most recent investment recorded for Amy Belt Raimundo closed in Mar 2022. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
